This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Cost-Effectiveness of Divalproex Versus Lithium

C. Bruce Baker, Scott W. Woods, and Michael J. Sernyak

Published: August 15, 1997

Article Abstract

Letter to the Editor

Sir: We read with interest the recent application by Keck et
al. of pharmacoeconomic analysis to the treatment of bipolar
disorder. Their study suggested that divalproex was more costeffective
in treating mixed and rapid cycling manic states, that
lithium was more cost-effective in treating classic mania, and
that divalproex was more cost-effective when mixed, rapid
cycling, and classic mania were combined. Like Keck et al.,
we noted the sensitivity of the model to assumptions about
the length of stay (LOS) for divalproex versus lithium.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 58

Quick Links: